Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Non-inferiority Trial Assessing the Osseointegration of THA Grafted by Sodium Polystyrene Sulfonate -PolyNASS- (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)

NCT03113981 is registered in ClinicalTrials.gov with Societe ACTIVBIOMAT as lead sponsor.

NCT NCT03113981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Non-inferiority Trial Assessing the Osseointegration of THA Grafted by Sodium Polystyrene Sulfonate -PolyNASS- (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)
Lead sponsor
Societe ACTIVBIOMAT
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 8, 2017
Completion date
December 31, 2039
Enrollment
340 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

coxarthrosis; primary, coxarthrosis; secondary, hip arthroplasty, hip arthroplasty replacement, hip arthroplasty, total, osteoarthritis, hip, osteonecrosis; aseptic, idiopathic